New pill shows promise for stubborn cough that Won't quit
NCT ID NCT05733533
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested an experimental drug called HRS-2261 in 97 adults with refractory chronic cough—a persistent cough that doesn't respond to usual treatments. Participants took the drug or a placebo for 4 weeks to see if it reduced cough severity and improved quality of life. The goal is to find a safe, effective option for people who have suffered from chronic cough for over a year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY CHRONIC COUGH are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, 510120, China